Dynamic Vessel Analyzer (DVA)
Dynamic Vessel Analyzer (DVA) is a medical device with 8 clinical trials. Currently 5 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
50.0%
1 of 2 finished
50.0%
1 ended early
5
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Retinal Neuro-vascular Coupling in Patients With Multiple Sclerosis
Investigation of Neurovascular Coupling in Glaucoma Patients and Healthy Subjects
Reproducibility of Dual Beam Doppler Fourier-domain Optical Coherence Tomography in Healthy Subjects
Retinal Neurovascular Coupling in Patients Previously Infected With COVID-19
Early Retinal Neurodegeneration As Risk Factor, Biomarker and Pharmacological Target of Diabetic Retinopathy
Clinical Trials (8)
Retinal Neuro-vascular Coupling in Patients With Multiple Sclerosis
Investigation of Neurovascular Coupling in Glaucoma Patients and Healthy Subjects
Reproducibility of Dual Beam Doppler Fourier-domain Optical Coherence Tomography in Healthy Subjects
Retinal Neurovascular Coupling in Patients Previously Infected With COVID-19
Early Retinal Neurodegeneration As Risk Factor, Biomarker and Pharmacological Target of Diabetic Retinopathy
Retinal Neuro-vascular Coupling in Patients With Non-arteritic Anterior Ischemic Optic Neuropathy
Fundus Oculi and Erectile Dysfunction
Effect of Simvastatin Withdrawal on Ocular Endothelial Function
All 8 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 8